SUBMASSIVE PULMONARY EMBOLISM: ARE WE FALSELY REASSURED BY NORMOTENSION?

Acute pulmonary embolism (PE) is associated with significant morbidity and mortality. Current risk stratification tools utilize clinical parameters such as blood pressure (BP), cardiac biomarkers, and evidence of right ventricular strain to prognosticate patients with acute PE. We sought to